Does RAVULIZUMAB Cause Off label use? 11 Reports in FDA Database

Q: Does RAVULIZUMAB cause Off label use?

11 reports of Off label use have been filed with the FDA for RAVULIZUMAB, representing 9.3% of all RAVULIZUMAB adverse event reports.

Q: How dangerous is Off label use from RAVULIZUMAB?

Of 11 reports, 1 (9.1%) resulted in death and 5 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Off label use have been filed in association with RAVULIZUMAB (Ultomiris). This represents 9.3% of all adverse event reports for RAVULIZUMAB.

Reports of Off label use with RAVULIZUMAB

9.3%

of all RAVULIZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Off label use From RAVULIZUMAB?

Of the 11 reports, 1 (9.1%) resulted in death, 5 (45.5%) required hospitalization, and 1 (9.1%) were considered life-threatening.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does RAVULIZUMAB Cause?

Pneumonia (8) Drug ineffective (5) Neuromyelitis optica spectrum disorder (5)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which RAVULIZUMAB Alternatives Have Lower Off label use Risk?

RAVULIZUMAB vs RAVULIZUMAB-CWVZ RAVULIZUMAB vs REBAMIPIDE RAVULIZUMAB vs REBETOL RAVULIZUMAB vs REBIF RAVULIZUMAB vs REBOXETINE

RAVULIZUMAB Full Profile All Off label use Reports All Drugs Causing Off label use RAVULIZUMAB Demographics